We have previously identified the tumor suppressor in lung cancer 1 (TSLC1) gene as a novel tumor suppressor in human non-small cell lung cancer (NSCLC) by functional complementation. TSLC1 encodes a membrane glycoprotein belonging to an immunoglobulin superfamily and participates in cell adhesion. A truncating mutation of the TSLC1 corresponding to its cytoplasmic domain in a primary NSCLC tumor suggests that this domain is important for tumor suppressor activity. Here, we report that TSLC1 directly associates with MPP3, one of the human homologues of a Drosophila tumor suppressor gene, Discs large (Dlg). This interaction was dependent on the presence of a PDZ-binding motif at the carboxyl terminus of TSLC1. Furthermore, TSLC1 and MPP3 were colocalized at the cell-cell attachment sites in both a low and a high cell density. The MPP3 gene was expressed in normal lung as well as in many tissues examined except for peripheral blood lymphocytes but lost its expression in one of the nine NSCLC cell lines. These results suggest that TSLC1 and MPP3 are involved in the same cascade of cell-cell interaction, and that the disruption of this cascade might lead cells to malignant growth and tumor formation in lung cancer.
Introduction
Lung cancer is the leading cause of cancer death. Therefore, the elucidation of the molecular mechanisms of lung cancer development is a critical issue to control this type of refractory cancer and offer better therapeutic approaches. We have previously identified the tumor suppressor in lung cancer 1 (TSLC1) gene on chromosome 11q23.2 by functional complementation through suppression of tumorigenicity of the human lung cancer cell line, A549 . Two-hit inactivation by loss of one allele and promoter methylation or truncating mutations in the other allele are observed in approximately 40% of primary NSCLC tumors as well as in 20-30% of tumors from the liver, pancreas, prostate, breast, and stomach Allinen et al., 2002; Fukuhara et al., 2002; Honda et al., 2002; Jansen et al., 2002; Murakami, 2002 ). An extracellular domain of TSLC1 contains three immunoglubulin-like C2-type loops showing significant homology with NCAM. We have reported that TSLC1 is a glycoprotein, which is expressed at the cell-attachment site and predominantly distributed in the lateral membrane in polarized epithelial cells. We have also shown that TSLC1 forms cis-homodimers and participates directly in cell aggregation, suggesting its involvement in cell adhesion .
On the other hand, the cytoplasmic domain of TSLC1 is relatively short of 46 amino acids but contains a couple of important motifs, a protein 4.1-binding motif just adjacent to the transmembrane domain and a PDZ-binding motif (class II) at the carboxyterminal end (Songyang et al., 1997; Fukuhara et al., 2001; Fukami et al., 2002) . We have recently demonstrated that the 4.1-binding motif is essential for the association of TSLC1 with DAL-1/4.1B, another tumor suppressor protein in lung cancer . The PDZ-binding motif also appeared to be critical for tumor suppressor activity because a truncating mutation of the TSLC1 that abrogated the carboxyterminal portion containing the PDZ-binding motif was observed in a primary NSCLC tumor. PDZ-binding motifs are known to interact with a number of proteins carrying PDZ domains, including a group of proteins showing structural homology with the Drosophila Discs large (Dlg) tumor suppressor protein. Such proteins, termed membrane-associated guanylate kinase homologues (MAGUKs) in mammals, are localized at the cell-cell junctions and appear to participate in both structural and signaling roles (Harris and Lim, 2001 ). Here, we explored the proteins binding to the cytoplasmic domain of TSLC1 and identified MPP3 (alias, MAGUK3), one of the human homologues of Dlg in Drosophila.
Results

Identification of DLG3 as a binding protein with TSLC1 by yeast two-hybrid screening
To identify possible binding proteins with TSLC1 through its cytoplasmic domain, we screened the human brain cDNA library by yeast two-hybrid expression cloning using the cytoplasmic region of TSLC1 as bait. After screening 1.7 million cDNA clones, we identified four independent clones that could activate a series of reporter genes in yeast cells. DNA sequencing analyses revealed that two of the four clones overlapped each other in the fragments of 1485 bp and were identical to the clone of human MPP3 cDNA (Figure 1 ). Human MPP3 is a cytoplasmic protein of 585 amino acids and belongs to the MAGUK family molecules, presenting a high homology with a Dlg (Smith et al., 1996) . The MPP3 protein contains a pair of Lin2/Lin7-binding (L27) domains, a PDZ domain, an Src-homology 3 (SH3) domain and a guanylate kinase homologous (GuK) domain. Two overlapping clones shared the sequence corresponding to the PDZ domain, suggesting that this domain could interact with the PDZ-binding motif in TSLC1 (Figure 1 ). Thus, we isolated a full-length cDNA of human MPP3 and confirmed the interaction with the cytoplasmic region of TSLC1 by repeating a yeast two-hybrid experiment using MPP3 as bait (data not shown).
Interaction of TSLC1 with MPP3 both in vivo and in vitro
A human embryonic kidney cell line, HEK293, expressed a significant amount of endogenous TSLC1 that can be detected by anti-TSLC1 polyclonal antibody (pAb), CC2 Yageta et al., 2002) . To analyse the possible association of TSLC1 with MPP3 in human cells, we transfected a plasmid expressing a full length of MPP3 tagged with V5 into HEK293 cells. Western blotting analysis of a whole-cell extract revealed that anti-V5 monoclonal antibody (mAb) specifically detected this exogenous MPP3 of about 75 kDa. When extracts of the cells were immunoprecipitated with anti-TSLC1 pAb, CC2, MPP3 was coprecipitated with the endogenous TSLC1 and subsequently detected by anti-V5 mAb, while no signals were detected when cell extracts were immunoprecipitated with IgG (Figure 2 ). These findings confirmed the results of the yeast two-hybrid experiment and strongly suggest that TSLC1 directly associates with MPP3 in vivo. Immunoprecipitation with anti-V5 mAb could not reciprocally detect coprecipitated TSLC1 in the same cell extracts, probably because the exogenously expressed MPP3 was much more abundant than the endogenous TSLC1.
To localize the binding activity of TSLC1 with MPP3, fragments corresponding to an entire cytoplasmic domain and a portion of a transmembrane domain of TSLC1 (TSLC-C), as well as a couple of deletion mutants, TSLC1-CD3 and TSLC1-CD9, which respectively lack three and nine amino acids at the cytoplasmic tail corresponding to a PDZ-binding motif, were expressed in Escherichia coli as fusion proteins with glutathione-S-transferase (GST) (Figure 3a) . A GST pull-down assay was then carried out with [ 35 S]methionine-labeled full-length MPP3, which was synthesized in reticulocyte lysate. GST/TSLC1-C strongly bound to MPP3, whereas the binding activity of GST/TSLC1-CD3 and GST/TSLC1-CD9 with MPP3 was significantly reduced to 22 and 20% of that of GST/TSLC1-C, respectively (Figure 3b ). When a GST pull-down assay was independently carried out with HA-tagged MPP3 derived from Cos-7 cells, only GST-TSLC1-C but not GST-TSLC1D9 associated with MPP3-HA. These results indicate that TSLC1 binds to MPP3 through its PDZ-binding motifs, in which three amino acids at the carboxyl end are critical for this interaction. Figure 1 Schematic representation of cDNA and the predicted amino acid structure of MPP3 (Smith et al., 1996 ; GenBank Accession number NM 001932). ATG and TAA indicate an initiation and a termination codon, respectively. Gray, black, hatched, and spotted boxes indicate L27, PDZ, SH3, and GuK domains, respectively. The inserts of two independent clones obtained by yeast two-hybrid screening are indicated at the top 
Colocalization of TSLC1 and MPP3 at cell-cell attached sites
Next, the subcellular localization of TSLC1 and MPP3 was examined using immunofluorescence microscopy. HEK293 cells expressing exogenous MPP3 tagged with V5 were stained with anti-TSLC1 pAb for TSLC1 (green) and anti-V5 mAb for V5 (red). When an early stage of cell adhesion was examined by culturing cells in a low density, both TSLC1 and MPP3 were localized primarily at the cell-cell attached sites (Figure 4a -c). When cells were cultured in confluence, TSLC1 and MPP3 colocalized all along the cell membrane ( Figure  4d -f). A significant portion of MPP3, however, was also present in the cytoplasm in both a low-and a highdensity culture, suggesting that only a subset of MPP3 might cooperate with TSLC1. Alternatively, a significant portion of MPP3 could not bind to TSLC1 because the exogenously expressed MPP3 was much more abundant than the endogenous TSLC1. In fact, only a small amount of endogenous MPP3 mRNA was detected in parental HEK293 cells by Northern blot analysis (data not shown). Since MAGUK family proteins are known to play a role in clustering the associated membrane proteins, localization of TSLC1 might be altered by overexpression of MPP3. However, TSLC1 showed the same distribution at the cell-cell attachment site in the parental HEK293 cells without exogenous MPP3 expression (Figure 4g ).
Expression of the MPP3 gene in human lung cancer cell lines
Association of MPP3 with a tumor suppressor protein, TSLC1, as well as its structural homology with Dlg, raised the possibility that the MPP3 could be another candidate tumor suppressor gene in human lung cancer. Smith et al. (1996) reported that the MPP3 gene was expressed in lung and all other tissues examined except for peripheral blood lymphocytes. This pattern of expression well corresponds to that of TSLC1 (Gomyo et al., 1999; Kuramochi et al., 2001 ). Thus we examined the expression of MPP3 in nine NSCLC cell lines by Northern blot analysis. As shown in Figure 5 , MPP3 was significantly expressed in lung, whereas the expression was lost in one of the nine lung cancer cell lines, ABC-1, suggesting that inactivation of MPP3 could be involved in a subset of human lung cancers.
Discussion
We demonstrated in the present study that MPP3, one of the human homologues of a Drosophila tumor suppressor Dlg, is an important binding partner of TSLC1. Association of MPP3 with the cytoplasmic domain of TSLC1 was initially identified by yeast twohybrid screening and then confirmed by immunoprecipitation coupled with Western blotting in vivo and by the GST pull-down assay in vitro. Colocalization of V5- Association of a lung tumor suppressor TSLC1 with MPP3 H Fukuhara et al tagged MPP3 with the endogenous TSLC1 at the cellcell attachment site, as well as the coincident pattern of expression of these two genes in various tissues, strongly supports the idea that TSLC1 physiologically associates with MPP3 in various tissues including lung. The subdomain of MPP3 protein responsible for association with TSLC1 would be the next thing to be determined. Detection of the endogenous MPP3 by a specific antibody would also be necessary for understanding the role of this protein-protein interaction in various physiological and pathological situations. Here, we demonstrated that subcellular distribution of TSLC1 was not affected by overexpression of MPP3. However, it would be interesting to see whether activity of cell aggregation by TSLC1 could be altered by coexpressing MPP3 or MPP3 mutants. Tumor suppressor activity of the TSLC1 mutant lacking the PDZ-binding motif is also being analysed, which would provide useful information for understanding the pathological significance of TSLC1-MPP3 interaction in lung carcinogenesis. The Drosophila tumor suppressor gene, Dlg is originally identified by the analyses of recessive lethal mutants. The flies carrying the germline mutations of both alleles of the Dlg gene showed loss of cell polarity, disruption of cell-cell adhesion and neoplastic overgrowth of the imaginal discs (Bryant and Schmidt, 1990) . Sequencing analysis of full-length cDNA revealed that the Dlg protein contains a PDZ, an SH3, and a GuK domain (Woods and Bryant, 1991) . It was recently demonstrated that Dlg is involved in asymmetric cortical localization of all basal determinants in mitogenic neuroblasts in concert with another Drosophila tumor suppressor protein, Lgl (Ohshiro et al., 2000; Peng et al., 2000) . Furthermore, Dlg is involved in the establishment of planar asymmetry of the sensory organ precursor cells regulated by Frizzled proteins (Bellaiche et al., 2001) . These findings suggest that Dlg plays a pivotal role in the normal control of cell growth coupled with the formation of cell polarity in the epithelial as well as the nervous cells in Drosophila.
In humans, a family of proteins termed MAGUKs shows significant homology with Drosophila Dlg. Its members, including MPP3, share one or three PDZ domains, an SH3 domain, and a GuK domain (Songyang et al., 1997) . These molecules are localized at the membrane-cytoskeleton interface, usually at cellcell junctions, and one of the family proteins, DLG1, was shown to interact with a tumor suppressor protein, APC (Matsumine et al., 1996) . However, no previous study had ever reported about the relationship between MPP3 and human cancer. We showed in the present study that MPP3 colocalized with TSLC1 at cell-cell attachment sites both in a low-and a high-density culture, suggesting that TSLC1 and MPP3 are cooperatively involved in normal cell adhesion. TSLC1 would transmit the signals of cell-cell attachment through MPP3 towards a series of downstream proteins that eventually inhibit cell growth. Additional molecules that interact with MPP3 through its SH3 or GuK domains would be involved in this tumor suppressor cascade.
We recently reported that TSLC1 associated with DAL-1, another lung tumor suppressor and an anchoring protein that interacts with f-actin through its cytoplasmic domain . Therefore, TSLC1, MPP3, and DAL-1 could associate with one another at the cell-cell attachment site. In this connection, it is noteworthy that glycophorin C, a red blood cell antigen showing a strong homology with TSLC1 in its cytoplasmic region, forms a ternary complex with MPP1 and protein 4.1 and is involved in the deformity of red blood cells (Funayama et al., 1991; Marfatia et al., 1995 Marfatia et al., , 1997 . Drosophila Neurexin IV, another transmembrane protein presenting a structural similarity with TSLC1 in the cytoplasmic region, also associates with Dlg and Coracle, a homologous molecule of the protein 4.1 (Fehon et al., 1994) . These complexes are shown to participate in the formation of a septate junction, a cell adhesion apparatus in Drosophila that is equivalent to a tight junction in vertebrate cells (Baumgartner et al., 1996) . These findings strongly suggest that the evolutionary conserved ternary complexes, consisting of a transmembrane protein such as TSLC1, a Dlg family protein, and a protein 4.1 family molecule, are involved in various situations of cell-cell interactions.
We found in a previous study that a primary lung tumor showed two-hit inactivation by loss of heterozygosity (LOH) and a frame-shift mutation in the last exon of the TSLC1 gene . This mutation caused a truncation of the cytoplasmic region of TSLC1, where the PDZ-binding motif, but not the 4.1-binding motifs, was abrogated (Figure 3 ). This finding would support the importance of the association with MPP3 for tumor suppressor activity by TSLC1. In the present study, we found a lack of MPP3 gene expression in one of the nine human NSCLC cell lines, ABC-1, although MPP3 was expressed in normal lung. Interestingly, ABC-1 cells expressed a significant amount of TSLC1 and DAL-1 , suggesting that loss of MPP3 expression might inactivate this tumor suppressor cascade in this lung adenocarcinoma cell line. In addition, LOH on Association of a lung tumor suppressor TSLC1 with MPP3 H Fukuhara et al chromosomal fragment 17q21, where the MPP3 gene was located, was frequently observed in various human cancers, including non-small cell lung cancer (Fong et al., 1995) . This evidence suggests that MPP3 could be another tumor suppressor in human lung cancer. Structural analyses searching for two-hit inactivation of the MPP3 gene, including promoter methylation, in primary lung tumors in combination with a functional study on the tumor suppressor activity by MPP3 would be required to determine whether MPP3 could be an authentic tumor suppressor gene in human lung cancer.
Materials and methods
Antibodies and human cell lines
A rabbit anti-TSLC1 antibody (CC2) raised against 18 synthetic polypeptides of the C-terminus of TSLC1 was described previously Yageta et al., 2002) . A monoclonal antibody against V5 (R-960-25) was purchased from Invitrogen (Carlsbad, CA, USA). Anti-rabbit IgG and anti-mouse IgG, each conjugated with the horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA, USA), were used as a secondary antibody for Western blotting. A FITC-conjugated donkey anti-rabbit IgG or rhodamine-conjugated donkey anti-mouse IgG (Jackson Immuno Research Lab., West Grove, PA, USA) was used as a secondary antibody for immunofluorescence staining. HEK293 cells and two human NSCLC cell lines, NCI-H441 and NCI-H596, were obtained from the American Type Culture Collection (Rockville, MD, USA). Human NSCLC cell lines, ABC-1, RERF-LC-MS, RERF-LC-OK, VMRC-LCD, and A431 cells, were from the Health Science Research Resources Bank (Osaka, Japan), while Cos-7, A549, and PC-14 cells were obtained from the RIKEN cell bank (Tsukuba, Japan).
Plasmids
A full-length cDNA of MPP3 was cloned into pcDNA3.1/V5-His (Invitrogen) or into pGBKT7 using appropriate restriction sites for expression analysis in human or yeast cells, respectively. For the construction of the expression vectors of GST-TSLC1 fusion proteins, three fragments corresponding to the various portions of the carboxyl terminus of TSLC1 were amplified by PCR from pcTSLC1 and subcloned into pGEX-4T-1 (Promega, Madison, WI, USA). Each fragment corresponds to the entire cytoplasmic domain of TSLC1 (TSLC1-CT; 392-442 amino acid (aa)), the cytoplasmic domain lacking three amino acids (TSLC1-CD3; 392-439 aa), or that lacking nine amino acids (TSLC1-CD9; 392-433 aa) at the carboxyl terminus. All constructs were verified by sequencing the inserts using the BigDye terminator cycle sequencing ready kit (Perkin-Elmer, Branchburg, NJ, USA) on an ABI 377 DNA auto-sequencer (Applied Biosystems, Foster City, CA, USA).
Yeast two-hybrid interaction cloning
Analysis of interaction using the yeast two-hybrid system was carried out as described (Golemis et al., 1996) . The fragment corresponding to the entire cytoplasmic domain of TSLC1 (392-442 aa) was amplified by PCR using pcTSLC1 (Kuramochi et al., 2001) as a template and subcloned into pGBKT7 to obtain a fusion protein with the DNA-binding domain of Gal4 (pGBKT7-TSLC1-CT). This plasmid was used to transform a Saccharomyces cerevisiae strain, PJ69-2A (James et al., 1996) . The AD fusion library supplied by Clontech (MATCH-MAKER) (Palo Alto, CA, USA), in which a human brain cDNA library was precloned into plasmid pGADT7 to express a series of fusion proteins with the DNA-activation domain of Gal4, was pretransformed into S. cerevisiae strain Y187. These two yeast strains were incubated together for 20-24 h, and then diploid colonies were selected on plates with synthetic complete media lacking tryptophan, leucin, histidine and adenine for 21 days at 301C. Positive clones were assessed by a filter assay for b-galactosidase activity (Vojtek et al., 1993) .
Immunoprecipitation and Western blotting
HEK293 cells were cotransfected with 2 mg of pcTSLC1 and 2 mg of pcDNA3.1/MPP3-V5. After 24 h, cells were washed and treated with a lysis buffer (150 mm NaCl, 20 mm Tris-HCl, pH 8.0, 1% Triton-X, 10% glycerol) on ice for 10 min and centrifuged. In total, 1 mg of the antibody was added to 500 mg of the cell lysate and incubated overnight at 41C, and then a 50% suspension of Protein A Sepharose 6MB (Amersham Pharmacia, Cleveland, OH, USA) was added and incubated for 1 h at room temperature. Beads were then washed four times with a lysis buffer and resuspended in a NuPAGE sample buffer (Invitrogen). Immunoprecipitates or 5 mg of whole-cell lysates were electrophoresed on 10% SDS-polyacrylamide gel and transferred onto a polyvinylene difluoride membrane with a semi-dry transfer blot system (Bio-Rad, Hercules, CA, USA). After blocking with TBS containing 1% Tween 20 and 5% skim milk for 30 min, the filters were incubated with primary antibody for 1 h, washed, and incubated with the appropriate HRP-labeled secondary antibody. Specific proteins were detected using an enhanced chemiluminescence system (Lumi-Light PLUS ; Roche, Basel, Switzerland).
GST pull-down assay The glutathion-S-transferase (GST)-TSLC1 fusion proteins expressed in E. coli were purified using glutathione sepharose 4B (Amersham Pharmacia). [ 35 S]methionine MPP3 was synthesized in reticulocytes from pcDNA3.1/ MPP3-V5-His using a TNT T7 Quick Coupled transcription/ translation system (Promega). HA-tagged MPP3 was purified from the extracts of Cos-7 cell transfected with pcDNA3.1/ MPP3-HA. For in vitro binding, radiolabeled or HA-tagged MPP3 proteins were incubated with equal amounts of GST-TSLC1 fusion proteins or GST coupled with glutathione sepharose beads for 1 h at 301C in an NETN buffer (20 mm Tris-HCl, pH 7.5, 150 mm NaCl, 1 mm EDTA, pH 8.0, 0.5% Nonidet P-40, 1 mm phenylmethylsulfonyl fluoride (PMSF), and 1 mm dithiothreitol). After incubation, the beads were washed with the NETN buffer and subjected to SDSpolyacrylamide gel electrophoresis (10% ready gel; Bio-Rad), then the gels were stained with Coomassie Brilliant Blue (ICN, Costa Mesa, CA, USA). Binding of 35 S-labeled proteins was detected by autoradiography, while binding of HA-tagged proteins was detected by anti-HA antibody. The intensity of the signals was quantified using a software, NIH Image version 1.63.
Immunofluorescence microscopy For colocalization studies of TSLC1 and MPP3, HEK293 cells stably expressing MPP3-V5 (HEK293/MPP3-V5) were prepared by transfecting HEK293 cells with pMPP3-V5 using Lipofectamine Plus reagent (Invitrogen) according to the manufacturer's protocol. Pooled clones were obtained in a medium containing 500 mg/ml of Geneticin (G418) (Invitrogen) and maintained in the presence of 300 mg/ml of G418. Parental HEK293 cells were also examined for subcellular localization of TSLC1. These cells were seeded on collagen I-coated eight-well culture slides (BIOCOAT; Becton Dickinson Labware, Bedford, MA, USA) a couple of days before fixation. The cells were washed twice in PBS (pH 7.2) and fixed with 4% paraformaldehyde in PBS for 20 min at room temperature (rt). For indirect fluorescent microscopy, fixed cells were permeabilized with 0.1% Triton in PBS for 5 min, washed three times with PBS, blocked for 30 min with 5% normal donkey serum (Chemicon International, Inc., Temecula, CA, USA) in PBS, and stained with the indicated primary antibodies diluted in 1% normal donkey serum overnight at room-temperature. After washing three times with PBS, fluorophore-conjugated secondary antibodies were applied for 1 h at rt and washed with PBS. The slides were mounted with an antifade reagent, Vectashield (Vactor Laboratories, Burlingame, CA, USA), covered with glass coverslips, and examined with a laser confocal scanning system, Radiance 2000 (Bio-Rad) equipped with a 488/514-nm argon and a 543-nm helium-neon laser.
Northern blotting Human adult brain and lung poly-A RNA were obtained from Clontech. Poly (A)
þ RNA from NSCLC cell lines was extracted using the FastTrack 2.0 kit (Invitrogen). Northern blot analysis was carried out using 2 mg of poly (A) þ RNA as described previously . For the detection of TSLC1, a 961-bp PCR-derived fragment corresponding to nucleotides 411-1371 was used as a probe . A cDNA probe for human beta-actin was purchased from Clontech. Signal intensity was quantified using BAS-2000 (Fuji Imaging System, Tokyo, Japan).
